Jonathan Barratt, MD, consultant nephrologist and professor of renal medicine, University of Leicester and John Walls Renal Unit, Leicester, provides a comprehensive overview of IgA nephropathy. Professor Barratt also discusses updates on new treatments for patients with IgA nephropathy.
In this heartfelt video, four different patients share their journies with IgA nephropathy, kidney failure, and the eventual need for a transplant. Initially unaware of their conditions, they…
Lauren Levy, MS, RDN, CSR, owner of Happy Health Nutrition, LLC, discusses considerations for kidney-friendly diets for patients with IgA nephropathy. She also discusses what parts of the…
Explore IgA nephropathy, a rare autoimmune kidney disease where the IgA protein builds up in the kidneys. Normally, IgA helps protect against infections, but in this condition, it…
Anand Reddy, MRCP (UK), FACP, FASN, Permian Regional Medical Center, Andrews, Texas; and Richard Lafayette, MD, FASN, professor of medicine and director of the Stanford Glomerular Disease Center,…
From different backgrounds and lifestyles, Elle, Jennifer, Tony, and Sean discuss their first-hand experiences with IgA nephropathy and the associated challenges of living with this rare disease.
Jennifer Vaughan, APRN, and Kenneth K. Afenya, MD, of Lex Kidney Care, Lexington, Kentucky, discuss the basics of IgA nephropathy, including signs and symptoms, as well as epidemiology…
Dana Rizk, MD, professor of medicine at the University of Alabama at Birmingham, discusses the approval of Fabhalta (iptacopan) for adults with IgA nephropathy. Iptacopan, a Factor B…
Dawn J. Caster, MD, FASN, associate professor of medicine, Division of Nephrology & Hypertension, University of Louisville School of Medicine, Louisville, Kentucky, discusses IgA nephropathy, including when to…
Julian, a kidney recipient, reflects on his experience with IgA nephropathy. Thanks to a successful transplant, Julian is able to continue his career. “I’m living a healthy, normal…
Dr. Richard Lafayette, founder and director of the Glomerular Disease Center at Stanford University Medical Center, discusses the prevalence and impact of IgA nephropathy, the most common primary…
